|
|
Lonza Group AG
/ Key words: Expansion
Lonza to Expand Bioconjugation in Visp CH with Two Additional Manufacturing Suites 12.11.2024 / 07:00 CET/CEST
The expansion of... Więcej |
|
| |
|
| |
|
|
Lonza Group AG / Key words: Quarter Results
Q3 2024 Qualitative Update: Lonza Confirms FullYear Outlook 2024 24Oct2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Więcej |
|
| |
|
| |
|
|
Lonza Group AG
/ Key words: Partnership/Agreement
Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of AntibodyDrug Conjugates 22.10.2024 / 07:00 CET/CEST... Więcej |
|
| |
|
| |
|
|
Lonza Group AG
/ Key words: Personnel
Lonza Nominates David Meline as Independent Board Member 03.10.2024 / 09:00 CET/CEST
David Meline brings extensive governance, fin... Więcej |
|
| |
|
| |
|
|
Lonza Group AG
/ Key words: Acquisition
Lonza Completes Acquisition of LargeScale Biologics Site in Vacaville US from Roche 01.10.2024 / 16:45 CET/CEST
The Vacaville site is one of the l... Więcej |
|
| |
|
| |
|
|
Lonza Group AG
/ Key words: Partnership
Lonza and Vertex Sign a LongTerm Commercial Supply Agreement for CASGEVY® exagamglogene autotemcel 24.09.2024 / 14:00 CET/CEST... Więcej |
|
| |
|
| |
|
|
Lonza Group AG
/ Key words: Bond
Lonza Prices EUR 1.2 Billion DualTranche Straight Bonds 28.08.2024 / 18:31 CET/CEST
Basel, Switzerland, 28 August 2024 – Lonza Finance Intern... Więcej |
|
| |
|
| |
Szukaj komunikat :
